News

FDA Approves Polypill Widaplik for Hypertension
By Lori Solomon HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The Cardiology Advisor19h
Widaplik, a Single Pill, Triple Combo Therapy for Hypertension, Gets FDA Approval
The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.
Medical Xpress2d
FDA approves polypill Widaplik for hypertension
The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The combination pill is the ...
Monthly Prescribing Reference5d
Widaplik, a Single Pill, Triple Combo Therapy for Hypertension, Gets FDA Approval
Widaplik is a single tablet, triple combination therapy for hypertension that is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved ...
Medscape1d
FDA Approves Triple Rx for Hypertension
The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.
Medical Dialogues1d
FDA Approves First Triple-Drug Polypill for Initial Hypertension Treatment
The FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of ...
MedPage Today1d
Polypill Approved for Hypertension, Including as Initial Therapy
The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...
PharmExec3d
FDA Approves George Medicines’ Widaplik for Hypertension
Widaplik marks the first and only FDA-approved triple combination medication that can be used as an initial therapy for patients with hypertension who require multiple drugs to reach their blood ...
Morningstar5d
George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including ...
WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...